1800 244 735

Helpline (02) 9874 9777

Working as a team: Changes in brain development mean some brain regions may be slacking off

The effect of the HD genetic expansion on brain development has been a hot topic in HD research. A team of researchers led by Dr. Sandrine Humbert at the Grenoble Institut Neurosciences, examined human fetal tissue to show that the mutant HD gene causes very early changes in the patterns of early brain development. But what type of influence do these changes in development actually have? People born with the mutant HD gene obviously survive and thrive for many years, and even decades before symptoms in the brain develop. So while these findings don’t suggest that developmental changes cause immediate effects, they do justify careful interpretation.

A little of this, a little of that

Before we start – a quick Bio 101 refresher might be helpful to clear up some jargon we commonly use. We talk about Huntington’s disease, but use the word huntingtin a lot. HD refers to the disease itself, and huntingtin refers to the gene and/or protein that causes the disease. Scientists think they’re clever and gave the gene/protein name a little twist just to be creative. Just be thankful they didn’t get really creative and name it something off the wall like sonic hedgehog, 18 wheeler, or tinman (real gene names, we promise).

And while the word “huntingtin” refers to both a gene and a protein, those are actually quite different. You can think of a gene as a recipe – it provides the written instructions on what to make. And the protein is the product – you can think of it like the product of a recipe, like a pie. So huntingtin the gene is the recipe for huntingtin the protein, which is the product.

Even though the huntingtin gene was discovered in 1993, there’s still a lot we don’t know about the function of this protein. One reason for that is because researchers have found that huntingtin actually has many functions – doing a little of this, and a little of that in cells all over the body, and throughout our lifespan. And while some of those functions are beginning to become clear, there’s still a lot left to learn.

One of the more recently proposed roles for the huntingtin protein involves a contribution to development of the brain. Remember – people who inherit the HD mutation have the genetic change that causes the disease from a time before they were even born. But in most HD patients, symptoms don’t appear for decades. One of the goals of HD researchers is to understand the very earliest changes caused by the HD mutation, to try and help map these changes and the later dysfunction that leads to HD symptoms.

To study very early changes in development, scientists have used mouse and cell models to identify functions for the huntingtin protein. Increasing evidence suggests that there are subtle changes in brain development in cells and mice that express the mutant HD gene. We recently wrote about development-related changes described in a mini-brain, 3D cell model of HD that you can read about here.

But, as you’re all aware, mice aren’t humans and models that look at cells grown in a dish can’t tell us the whole story of what HD is doing in humans. As we often say, only humans get Huntington’s disease. And the reason researchers are studying HD is to find a treatment for humans with HD. So the best samples to use to look at this process are, well, from humans.

The right place at the right time – is it critical?

To determine if HD causes cellular changes during very early stages of human brain development, researchers led by Dr. Humbert examined the developing brain in human fetuses that were at 13 weeks of gestation. This provides researchers with information on what’s happening at a very specific point in time during early development – like a photograph of a specific moment.

They specifically looked at the developing cortex – the wrinkly outer bit of brain that executes many of our sophisticated behaviors. In the human fetal tissue carrying the HD mutation, the rate at which cells divided was slower and their location within the brain was altered. This was also seen in a mouse model, suggesting that these effects are definitely related to the HD mutation.

As a cell matures into a neuron, it physically moves in the brain. So at this time point in development, some cells aren’t in the right place at the right time, tipping the balance in the developing brain.

The take home message is that this study showed that cells in a certain area of the brain at a specific time point had differences in development because of the mutation that causes HD. However, it’s important to know that making brain cells as an adult is a very different process than when brain cells are first made during development. So while this study examines how the HD mutation is affecting the development of brain cells, it doesn’t look at changes in the formation of adult brain cells or why new cells don’t replace them. Those are questions for another study.

But many other studies in mice have shown us that even with the mutation that causes HD, a fully functional brain ultimately develops. And we certainly know this to be true in people.

Working together

So how can a brain have altered development and function normally? Other areas of the brain help out! It’s like when you have to do a group project, but one team member is a slacker – the rest of the team does a little bit extra to get the job done.

In fact, we’ve seen that this is the case in other studies from humans. A recent study – the ChANGE-HD study – used MRI to look at the sizes of various brain areas in kids (ages 6 to 18) who have inherited the HD mutation, but are many years from symptom onset. With consent from their parents, these kids participated in this study, aimed at understanding the earliest detectible changes in people carrying the HD mutation.

Compared to kids who don’t inherit the HD mutation, kids who do initially have a slightly larger striatum (an area of the brain that eventually experiences heavy cell loss due to HD) that decreased in size with age. But the kids who inherited the HD mutation also had more connections between other areas of their brains and this same brain region.

This suggests that the kids who inherit the HD mutation have faster development in certain brain areas affected by HD early on, and that this same brain region eventually shrinks over time. But other areas of the brain appear to be reaching out to help compensate for this altered developmental timeline. So the other areas of the brain pick up the slack for the brain region not pulling its own weight.

Structure doesn’t immediately determine function

Never underestimate a team that works well together. While each member might not be performing their function exactly how they’re assigned, they get used to working together. And it might take a very long time before cracks begin to appear in their way of doing things.

We learned recently from the HD Young Adult Study (HD-YAS) that even 24 years from predicted symptom onset, people carrying the HD mutation showed no decline in thinking or mood. (You can read more about the HD-YAS study here.) Even though HD may cause subtle changes in brain development that appear to be present from before birth, other studies show us that changes in development don’t appear to cause symptoms that we can measure. So it’s likely that the brain is able to compensate for these early changes.

With this new study, we have more evidence that huntingtin is involved in brain development, adding to the growing list of functions performed by this protein. Understanding exactly how huntingtin is involved in this process will help reveal things about human development overall. And it gives us a peak at some really cool development-related science!

Findings from this new study also beg the questions – what exactly are the mechanisms that compensate to keep HD brains healthy for so long? And can we identify them to extend that process as a therapeutic strategy? We still have a lot to learn about that area of HD research, but future studies are likely to follow up.

Latest Research Articles

Update on the PTC Therapeutics PIVOT-HD Trial

Published date: 2 November, 2022

Recruitment of participants into the US arm of the PTC Therapeutics PIVOT-HD trial has been paused. Since this announcement, there have been a lot of different (and confusing!) headlines about the pause in recruitment. In this article, we will lay out what is going on and what this announcement means. What is the aim of ... Read more

Forward momentum for Roche and Wave in latest news about huntingtin-lowering trials

Published date: 30 September, 2022

In the past week or so, during and following a big HD research conference, two companies developing medicines for Huntington’s disease announced news about their huntingtin-lowering drugs. First, the pharmaceutical company Roche announced plans for a new clinical trial of tominersen. Then, the genetic medicines company Wave Life Sciences shared early data showing that its ... Read more

Focusing in on fibrils; scientists give us a glimpse of huntingtin protein clumps

Published date: 8 September, 2022

A group of scientists from the EPFL in Lausanne, Switzerland have published a paper in the Journal of the American Chemical Society, describing clumps made up of a fragment of the huntingtin protein. A word that’s commonly used to describe these is “aggregates.” Using very powerful microscopes, the team was able to zoom in and ... Read more

Hereditary Disease Foundation (HDF) conference 2022 – Day 4

Published date: 2 September, 2022

DNA repair and CAG repeat instability The effect of HTT lowering on CAG repeat expansions Welcome to last day of the @hdfcures conference! We’ll only be sharing a few talks from today’s sessions, which focus on DNA repair. The first is from HDBuzz’s very own Jeff Carroll! Jeff will be sharing his work on HTT ... Read more

Hereditary Disease Foundation (HDF) conference 2022 – Day 3

Published date: 1 September, 2022

Pre-clinical work moving toward trials New tools to lower HTT showing promise in animal models Welcome back! The first talk we will be tweeting about today is from Anastasia Khvorova, who will be telling us about her teams work on lowering of Huntingtin using technology called RNAi. One of the problems in studying drug delivery ... Read more

Hereditary Disease Foundation (HDF) conference 2022 – Day 2

Published date: 31 August, 2022

We’re back for day 2 at @hdfcures! This morning’s talks will be focused on clinical trial planning and therapeutic updates from clinical studies. The sheer number of talks related to human trials compared to previous years is so encouraging! Updating metrics for clinical trials A better system for disease categorization The first talk of this ... Read more